podophyllotoxin has been researched along with Remission, Spontaneous in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aur, RJ; Avery, TL; Bowman, WP; Dahl, GV; Rivera, G; Wood, A | 1 |
| Bergevin, PR; Bloomfield, CD; Cuttner, J; Ellison, RR; Falkson, G; Holland, JF; Kennedy, BJ; Kung, F; Leone, LA; Nissen, NI; Pajak, TF; Silver, RT; Weiss, RB | 1 |
| Aur, RJ; Avery, TL; Dahl, GV; Pratt, CB; Rivera, G; Wood, A | 1 |
| Ahmann, DL; Decker, DA; Eagan, RT; Hahn, RG; Ingle, JN; Rubin, J | 1 |
| Falkson, G; Falkson, HC; van den Bergh, JA; van der Merwe, AM; van Dyk, JJ; van Eden, EB | 1 |
| Beckmann, C; Flury, R; Frei, P; Holdener, E; Jungi, WF; Senn, HJ | 1 |
| Dombernowsky, P; Hansen, HH; Hansen, M; Hirsch, F | 1 |
| Ferguson, A; Hewitson, R; Levin, W; Sealy, R; Tucker, RD; Van Wyk, C | 1 |
| Baker, LH; Fraile, RJ; Samson, MK; Talley, RW | 1 |
| Jankowski, RP; Vahrson, H | 1 |
| Buge, A; Poisson, M; Pouillart, P | 1 |
| Bleyer, WA; Chard, RL; Hammond, D; Krivit, W | 1 |
| Creagan, ET; Eagan, RT; Fleming, TR; Frytak, S; Ingle, JN; Kvols, LK; Rubin, J | 1 |
| Dubovsky, D; Jacobs, P; Kernoff, L | 1 |
| Agusti, A; Estape, J; Lloret, JS; Milla, A; Palacin, A; Soriano, E | 1 |
| Albahary, C; Amiel, JL; Belpomme, D; de Vassal, F; Depierre, R; Hayat, M; Jasmin, C; Mathé, G; Misset, JL; Musset, M; Pouillart, P; Schwarzenberg, L | 1 |
| Clink, HM; Gerken, ME; McElwain, TJ; Smith, IE | 1 |
| Buge, A; Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, HT | 1 |
| Kenis, Y; Rozencweig, M; Schulman, CC; Staquet, M; Sylvester, R | 1 |
| Brunner, KW; Cavalli, F; Hasler, E; Martin, J; Ryssel, HJ; Sonntag, RW; Tschopp, L | 1 |
| Mechl, Z; Rovný, F; Sopková, B | 1 |
| Ahmann, DL; Bisel, HF; Eagan, RT | 1 |
| Batz, K; Brunner, KW; Cavalli, F; Ryssel, HJ; Sonntag, RW | 1 |
| Amiel, JL; Mathé, G; Misset, JL; Oldham, R; Pouillart, P; Schwarzenberg, L; Weiner, R | 1 |
| Brachetti, A; Leonhardt, A; Limburg, H; Osswald, H; Schmähl, D | 1 |
| Amiel, JL; Céoara, B; de Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Oldham, R; Pouillart, P; Schneider, M; Schwarzenberg, L; Steresco-Musset, M; Weiner, R | 1 |
| Alberto, P; Giger, K; Nagel, G; Senn, HJ; Sonntag, RW | 1 |
| Larsen, V; Nissen, NI; Pedersen, H; Thomsen, K | 1 |
| Mann-Kaplan, RS; Reynolds, AF; Rosenblum, ML; Sklansky, BD; Walker, MD | 1 |
12 trial(s) available for podophyllotoxin and Remission, Spontaneous
| Article | Year |
|---|---|
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B.
Topics: Adult; Bone Marrow; Child; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Male; Neoplasms; Podophyllotoxin; Remission, Spontaneous | 1980 |
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer.
Topics: Bone Marrow; Breast Neoplasms; Cardiomyopathies; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Podophyllotoxin; Remission, Spontaneous; Time Factors | 1980 |
[The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)].
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Vomiting | 1977 |
[A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)].
Topics: Adult; Brain Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Glioma; Humans; Lomustine; Nitrosourea Compounds; Podophyllotoxin; Procarbazine; Random Allocation; Remission, Spontaneous; Teniposide; Time Factors | 1978 |
Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Child; Clinical Trials as Topic; Drug Evaluation; Humans; Leukemia; Leukemia, Lymphoid; Neoplasms; Neuroblastoma; Podophyllotoxin; Remission, Spontaneous; Teniposide | 1979 |
VP 16-213 in acute myelogenous leukaemia.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous | 1976 |
[Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial].
Topics: Adult; Aged; Brain Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Remission, Spontaneous; Teniposide | 1976 |
EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma.
Topics: Carcinoma, Papillary; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Postoperative Care; Remission, Spontaneous; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1976 |
Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Vincristine | 1976 |
Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.
Topics: Adult; Aged; Agranulocytosis; Alopecia; Antineoplastic Agents; Female; Glycosides; Hodgkin Disease; Humans; Lactones; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nausea; Neoplasms; Neutrophils; Podophyllotoxin; Remission, Spontaneous; Thrombocytopenia; Vomiting | 1973 |
Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213).
Topics: Animals; Cells, Cultured; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Glycosides; Haplorhini; Hemoglobins; Hodgkin Disease; Humans; Lethal Dose 50; Macaca; Mice; Neoplasm Transplantation; Neoplasms; Podophyllotoxin; Remission, Spontaneous; Solubility; Time Factors; Transplantation, Homologous | 1972 |
Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Anemia, Aplastic; Antineoplastic Agents; Blood Platelet Disorders; Child; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Glycosides; Hematopoiesis; Hodgkin Disease; Humans; Lactones; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Remission, Spontaneous; Thiophenes; Urinary Bladder Neoplasms | 1972 |
20 other study(ies) available for podophyllotoxin and Remission, Spontaneous
| Article | Year |
|---|---|
VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
Topics: Adolescent; Antineoplastic Agents; Bone Marrow Diseases; Child; Child, Preschool; Cytarabine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Podophyllotoxin; Remission, Spontaneous; Teniposide | 1980 |
Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
Topics: Adolescent; Adult; Bone Marrow; Child; Child, Preschool; Cytarabine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hypotension; Leukemia, Lymphoid; Male; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide | 1980 |
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Administration, Oral; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Glucosides; Humans; Leukemia, Myeloid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Mesothelioma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Urinary Bladder Neoplasms | 1975 |
Epipodophyllotoxin (VP 16-213) in the treatmetn of diffuse histiocytic lymphoma.
Topics: Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Prospective Studies; Remission, Spontaneous | 1975 |
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors].
Topics: Adenocarcinoma; Bronchial Neoplasms; Carcinoma; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Remission, Spontaneous | 1975 |
Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside).
Topics: Administration, Oral; Aged; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous; Solutions | 1977 |
Chemotherapy of small cell carcinoma of the lung with V.P. 16-213.
Topics: Bone Marrow; Carcinoma, Small Cell; Disability Evaluation; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Podophyllotoxin; Recurrence; Remission, Spontaneous; Time Factors | 1978 |
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Thrombocytopenia | 1978 |
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Time Factors; Vomiting | 1979 |
Rapid remission induction in adult acute non-lymphoblastic leukaemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous; Sepsis; Time Factors | 1978 |
VP 16-213 (VP 16) and cyclophosphamide in the treatment of primitive lung cancer in phase M 1.
Topics: Adult; Aged; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prednisone; Remission, Spontaneous; Vincristine | 1979 |
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Seeding; Podophyllotoxin; Prednisone; Remission, Spontaneous; Teniposide | 1975 |
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Topics: Adenocarcinoma; Anaplasia; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Vincristine | 1977 |
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
Topics: Carcinoma, Papillary; Humans; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide; Time Factors; Urinary Bladder Neoplasms | 1977 |
[Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Chemical Phenomena; Chemistry; Chronic Disease; Drug Evaluation; Female; Glucosides; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous | 1975 |
Combination chemotherapy based on a model of cell recruitment by partial synchronization.
Topics: Drug Therapy, Combination; Humans; Mitosis; Mitotic Index; Models, Biological; Neoplasm Metastasis; Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Time Factors; Vincristine | 1975 |
[Clinical experiences with a combination therapy of metastasising genital and mammary carcinomas (author's transl)].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Cyclophosphamide; Cytidine; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Podophyllotoxin; Postoperative Care; Prognosis; Remission, Spontaneous; Thymidine; Uterine Cervical Neoplasms; Vinblastine | 1974 |
[Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].
Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Leukemia, Myeloid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous | 1974 |
Experience with 4'-demethylepipodo-phyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis.
Topics: Adult; Aged; Antineoplastic Agents; Blood Platelet Disorders; Dose-Response Relationship, Drug; Female; Glucosides; Glycosides; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous; Thiophenes | 1974 |
Proceedings: 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms.
Topics: Adolescent; Adult; Anemia; Astrocytoma; Brain Neoplasms; Carcinoma, Bronchogenic; Child; Ependymoma; Evaluation Studies as Topic; Female; Glioma; Humans; Leukopenia; Male; Medulloblastoma; Middle Aged; Neoplasm Metastasis; Neurologic Examination; Podophyllotoxin; Remission, Spontaneous; Thrombocytopenia | 1974 |